Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease hepatitis c
Symptom C0023895|liver disease
Sentences 83
PubMedID- 22172892 A 43-year-old man with end-stage liver disease due to hepatitis c and b virus infections and alcoholic cirrhosis received a liver transplantation under immunosuppressive treatment with tacrolimus and mycophenolate mofetil.
PubMedID- 22087124 Background: nonalcoholic fatty liver disease develops in patients with chronic hepatitis c.
PubMedID- 25805611 A 51 years old male patient with end stage liver disease due to chronic hepatitis c virus infection received a right hemi-liver graft from his brother.
PubMedID- 21188525 Dietary history and physical activity and risk of advanced liver disease in veterans with chronic hepatitis c infection.
PubMedID- 25848478 However, chronic hepatitis c is associated with a higher liver disease related cardiovascular and all-cause mortality of hd patients.
PubMedID- 22318146 hepatitis c virus (hcv) leads to progressive liver disease and hepatocellular carcinoma.
PubMedID- 22457795 It is known that most cases of hcc developed from a pre-existing chronic liver disease, usually due to hepatitis c virus, hepatitis b virus or alcohol.
PubMedID- 20531062 Objective: liver disease associated with hepatitis c virus (hcv) is a serious cause of mortality among people living with human immunodeficiency virus/acquired immunodeficiency syndrome (hiv/aids) (plwha).
PubMedID- 24575168 Conclusion: genetic mutations that cause inherited liver diseases in patients with hepatitis c should be studied in detail.
PubMedID- 20388084 Most cases of hcc develop on a pre-existing chronic liver disease, usually due to hepatitis c virus (hcv), hepatitis b virus (hbv), or alcohol.
PubMedID- 22419479 We enrolled 184 hepatitis c-infected patients with chronic liver diseases or hcc, 57 healthy subjects and 27 hcc patients with other etiology.
PubMedID- 22359532 Nested case control studies have a distinct advantage from traditional case control studies because both cases and controls are chosen from the same, well-defined source population, in this study from the halt-c study population where all patients had chronic hepatitis c infection with chronic liver disease.
PubMedID- 25274075 In haemophilia, acetaminophen often has limited efficacy at therapeutic doses, offering a narrow dosing range in those with liver disease due to chronic hepatitis c.
PubMedID- 22160684 In a significant portion of patients chronic hepatitis c infection leads to serious liver diseases, including fibrosis, cirrhosis, and hepatocellular carcinoma.
PubMedID- 21029257 Uptake of hepatitis c antibody testing in patients with end-stage liver disease in glasgow, 1993-2007.
PubMedID- 24516785 Abstract: hepatitis c virus infection leads to liver disease whose severity can range from mild to serious lifelong illness.
PubMedID- 26503379 Moderate sustained virologic response rates with 6-week combination directly acting anti-hepatitis c virus therapy in patients with advanced liver disease.
PubMedID- 22058086 End-stage liver disease due to chronic hepatitis c is the main indication for liver transplantation 2.
PubMedID- 21918437 Management of end-stage liver disease in hiv/hepatitis c virus co-infection.
PubMedID- 21209701 End-stage liver disease due to hepatitis c (hcv) and cirrhosis from alcohol (ald) are the commonest indications for liver transplantation in the western countries.
PubMedID- 26444967 Are anti-tnf-alpha agents safe for treating psoriasis in hepatitis c virus patients with advanced liver disease.
PubMedID- 19902246 Antiviral therapy of chronic hepatitis c in patients with advanced liver disease and after liver transplantation.
PubMedID- 21743223 She was suffering from end-stage liver disease due to hepatitis c virus (hcv) infection and renal disease due to diabetic nephropathy.
PubMedID- 22505377 Background/aims: hepatitis c virus leads to chronic liver disease, cirrhosis and hepatocellular cancer.
PubMedID- 22098185 Evaluation of the adverse effect of premature discontinuation of pegylated interferon alpha-2b and ribavirin treatment for chronic hepatitis c virus infection: results from kyushu university liver disease study.
PubMedID- 24723944 Had underling liver disease with mostly hepatitis c virus (hcv) serologically positive (123/271, 45.4%) but not with hbv (78/271, 28.8%); however, the patients in our study were most hbv serologically positive (312/413, 75.5%).
PubMedID- 25030555 Association between gene polymorphisms of connective tissue growth factor and the progression of chronic liver disease associated with hepatitis c.
PubMedID- 22542039 liver disease due to chronic hepatitis c is now a leading cause of mortality among hiv-infected patients in the developed world.
PubMedID- 26138651 Background: rising rates of obesity, diabetes mellitus (dm), and nonalcoholic fatty liver disease among patients with chronic hepatitis c virus infection (hcv) may contribute to more rapid disease progression.
PubMedID- 20713178 Prevalence and challenges of liver diseases in patients with chronic hepatitis c virus infection.
PubMedID- 21957404 Fifteen patients suffered from end-stage liver disease due to hepatitis c; 7, due to hepatitis c with hepatocellular carcinoma; and the remaining 3, due to hepatocellular carcinoma with negative viral markers.
PubMedID- 25288416 We found nationwide trends in increasing morbidity and medical costs for advanced liver disease associated with hepatitis c.
PubMedID- 21809486 The purpose of this study was to determine the serum level of oxidized low-density lipoprotein (ox-ldl), and evaluate its association with different clinically valuable parameters of liver disease in patients with chronic hepatitis c.
PubMedID- 21128862 liver disease in patients with chronic hepatitis c virus (hcv) infection has an accelerated course in the presence of human immunodeficiency virus (hiv) coinfection.
PubMedID- 20678018 End-stage liver disease due to hepatitis c virus infection (hcv) is the principal indication for liver transplantation.
PubMedID- 23707779 Dietary cholesterol intake is associated with progression of liver disease in patients with chronic hepatitis c: analysis of the hepatitis c antiviral long-term treatment against cirrhosis trial.
PubMedID- 22163170 The most common indication for lt was end-stage liver disease attributed to hepatitis c infection.
PubMedID- 19800334 Background & aims: human immunodeficiency virus (hiv) infection accelerates liver disease progression in patients with hepatitis c virus (hcv) and could shorten survival of those awaiting liver transplants.
PubMedID- 21280186 A 52-year-old man had end-stage liver disease due to hepatitis c and pphtn; the latter showed a suboptimal response to pulmonary vasodilator therapy with continuous intravenous treprostinil sodium and oral sildenafil citrate and was considered a contraindication to isolated lt.
PubMedID- 23241078 The economic burden of advanced liver disease among patients with hepatitis c virus: a large state medicaid perspective.
PubMedID- 22721429 An infection of hepatitis c virus may lead to serious liver diseases including chronic hepatitis, cirrhosis and hepatocellular carcinoma with poor prognosis .
PubMedID- 23956763 Chronic hepatitis b virus (hbv) or hepatitis c virus infection leads to liver disease.
PubMedID- 20104219 Conclusions: measures of cognitive function were neither influenced by low-dose peginterferon treatment nor with objective evidence of liver disease progression in patients with advanced chronic hepatitis c prospectively followed up for 3.5 years.
PubMedID- 21326625 The patient's past medical history was significant for end-stage liver disease due to hepatitis c and hepatitis b, asthma, and erythropoietic porphyria.
PubMedID- 21057160 Twenty-one patients (62%) had liver disease associated with hepatitis c virus (hcv) and 5 patients with hepatitis b virus (62%).
PubMedID- 20386865 The mechanisms by which alcohol consumption accelerates liver disease in patients with chronic hepatitis c virus (hcv) are not well understood.
PubMedID- 25716364 Functional and morphological myocardial changes in hepatitis c virus patients with end-stage liver disease.
PubMedID- 21031537 Liver transplantation is currently the only definitive modality for the treatment of end-stage liver disease due to chronic hepatitis c.
PubMedID- 23763386 Aim: in chronic liver disease associated with hepatitis c virus (hcv), a low platelet count is a major obstacle in carrying out interferon (ifn) treatment.
PubMedID- 23796722 Methods: two patients, who had already received a liver transplant (lt) in the past, with an end-stage liver disease due to recurrent hepatitis c virus cirrhosis, suffering acute-on-chronic liver failure while on the waiting list for an lt, received ht as a bridge to whole-organ retransplantation.

Page: 1 2